Skip to main content
INBX logo
INBX
(NASDAQ)
Inhibrx Biosciences, Inc.
$63.53-- (--)
Loading... - Market loading

Inhibrx Biosciences (INBX) Stock Price & Financial Analysis

Inhibrx Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$63.13 - $66.00
52-Week High$94.57
52-Week Low$10.81
Open$64.77
Volume190.00K
Average Volume (3M)190.00K
Market Cap983.32M
Shares Outstanding15.48M
Price to Sales (P/S)741.29
Price to Book (P/B)28.18
EV/EBITDA-6.88
Revenue (TTM)1.40M
Net Income (TTM)-155.09M
Free Cash Flow (TTM)-143.44M
EPS (TTM)$-10.02
Profit Margin-11077.57%
Operating Margin-11002.14%
Return on Equity (ROE)-421.09%
Debt to Equity2.77
50-Day MA$73.95
200-Day MA$53.38
52-Week Change377.22%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateMay 30, 2024

Frequently Asked Questions About Inhibrx Biosciences

What is the current stock price for INBX?

As of the latest trading session, INBX stock trades at $63.53. The 52-week range is $10.81–$94.57, with a day range of $63.13–$66.00.

What is the P/E ratio for INBX?

The P/E ratio (Price-to-Earnings) for INBX is shown in the Key Statistics section. This valuation metric helps compare Inhibrx Biosciences, Inc. to industry peers.

Does INBX pay dividends?

Inhibrx Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for INBX?

Analyst ratings and recommendations for INBX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of INBX?

Inhibrx Biosciences's market capitalization is $983.3M, classifying it as a small-cap company. Inhibrx Biosciences operates in the Healthcare sector within the Biotechnology industry.